Kiora Pharmaceuticals, Inc. Analysis
| Analyst Ratings |
|
Average Target Price
|
64.50
|
|
Average Rating
|
4.00
|
|
# Strong Buys
|
1
|
|
# Buys
|
1
|
|
# Holds
|
1
|
|
# Sells
|
0
|
|
# Strong Sells
|
0
|
| Quarterly Earnings History |
| Quarter |
EPS Estimate |
EPS Actual |
EPS Difference |
Surprise Percent |
|
2022-12-31
|
-4.13
|
0.00
|
4.13
|
100.00%
|
|
2022-09-30
|
-3.83
|
-6.03
|
-2.20
|
-57.44%
|
|
2022-06-30
|
-9.40
|
-10.80
|
-1.40
|
-14.89%
|
|
2022-03-31
|
-9.20
|
-26.47
|
-17.27
|
-187.72%
|
|
2021-12-31
|
-0.30
|
-0.66
|
-0.36
|
-120.00%
|
|
2021-09-30
|
-13.47
|
-11.60
|
1.87
|
13.88%
|
|
2021-06-30
|
-16.67
|
-14.00
|
2.67
|
16.02%
|
|
2021-03-31
|
-15.40
|
-14.80
|
0.60
|
3.90%
|
| Annual Earnings History |
| Fiscal Year End |
EPS |
|
2022-12-31
|
-43.30
|
|
2021-12-31
|
-41.06
|
|
2020-12-31
|
-39.21
|
|
2019-12-31
|
-2.31
|
|
2018-12-31
|
-4.95
|
|
2017-12-31
|
-6.41
|
|
2016-12-31
|
-1.51
|
|
2015-12-31
|
-16.11
|